Wird geladen...

Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells

Estrogen receptor-α (ER) targeted therapies are routinely used to treat breast cancer. However, patient responses are limited by resistance to endocrine therapy. Breast cancer cells resistant to the pure steroidal ER antagonist fulvestrant (fulv) demonstrate increased activation of epidermal growth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zhang, Xihong, Diaz, Michael R., Yee, Douglas
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2013
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3711713/
https://ncbi.nlm.nih.gov/pubmed/23686416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-013-2541-y
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!